NCT00611897View on ClinicalTrials.gov

N-acetylcysteine and NMDA Antagonist Interactions

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Cognitive Dysfunction
Interventions
DRUG

N-acetylcysteine and ketamine

Active drug (N-acetylcysteine)

DRUG

placebo and ketamine

placebo N-acetylcysteine

Trial Locations (1)

06516

VHA Connecticut, West Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT00611897 - N-acetylcysteine and NMDA Antagonist Interactions | Biotech Hunter | Biotech Hunter